Healthy Volunteers Clinical Trial
Official title:
Relaxing Effects of Acupuncture, Sham Acupuncture or no Acupuncture, Given by Therapists Delivering Positive or Neutral Communication Regarding Expected Effects
Verified date | March 2018 |
Source | Västernorrland County Council, Sweden |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Background: The communication between a patient and clinician may have significant effects on
treatment outcomes and one likely mediator of the communication-related treatment effects is
patient expectations, as demonstrated by placebo studies in various clinical domains. To
investigate the link between patient-clinician interactions and patient expectancy in a
clinical setting, acupuncture is suggested an effective method, as acupuncture is a procedure
with known non-specific treatment components. As a scene for investigating the importance of
expectations on treatment outcomes, the investigators used acupuncture for relaxation
effects. It is commonly reported that participants experience a sense of relaxation during
acupuncture treatment, yet, it is not known if the effects are related to the specific
effects of needling or non-specific effects associated with the treatment procedure.
Aim: To investigate if communication type (positive or neutral) about the expected treatment
outcome affected i) participants' expectations, ii) short-term relaxation effects in response
to genuine or sham acupuncture or to rest, and to investigate if treatment expectations were
related to outcome.
Procedure: Volunteers, i.e. Swedish individuals in general, not part of any specific patient
group, are given written and oral study information and are screened for study criteria. The
volunteers giving informed consent are randomized to one treatment session a´30 minutes with
a) genuine acupuncture or b) sham acupuncture (telescopic non-penetrating needles).
They are compared to a non-randomized reference group that receive no acupuncture, just 30
minutes of rest.
Within the three groups, participants are randomized to 1) positive communication or 2)
neutral communication from therapists, regarding expected treatment effects.
Outcome measures: Visual analogue scales (VAS) (0-100 millimeter) measured treatment
expectations and relaxation, at baseline two hours before the treatment session, pre
treatment (directly before the treatment session) and post treatment (directly after the
treatment session). Heart rate, blood pressure, and salivary cortisol are measured pre and
post treatment. Primary endpoint is change in relaxation pre to post treatment.
Status | Completed |
Enrollment | 363 |
Est. completion date | April 2017 |
Est. primary completion date | April 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - minimum age 18 years, - physical, mental and linguistic capacity to give informed consent, e.g. understand Swedish Exclusion Criteria: - previous education in acupuncture therapy, in terms of being an acupuncture therapist. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Västernorrland County Council, Sweden | Linkoeping University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in relaxation from pre to post treatment. | Visual Analogue Scale (VAS) 0-100 mm, where 0 is "not relaxed at all" and 100 is "completely relaxed". | Directly before treatment and directly after treatment. | |
Secondary | Change in treatment expectations | Visual Analogue Scale (VAS) 0-100 mm, where 0 represents "expects treatment to have no effect" and 100 represents "expects treatment to have full effect". | Two hours before treatment, directly before and directly after treatment | |
Secondary | The participant´s Health status | Euro Qol barometer, 0-100 mm, where 0 represents "worst Health imaginable" and 100 "best Health imaginable" | Two hours before treatment | |
Secondary | Change in Heart rate in beats per minute | Digital wrist blood pressure monitor | Directly before treatment and directly after treatment | |
Secondary | Change in systolic Blood pressure in mm Hg | Digital wrist blood pressure monitor | Directly before treatment and directly after treatment | |
Secondary | Change in diastolic Blood pressure in mm Hg | Digital wrist blood pressure monitor | Directly before treatment and directly after treatment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |